A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial Carcinoma
Clinical trial NCT04501094 · TERMINATED
Trial details
- NCT number
- NCT04501094
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-26
- Primary completion
- 2021-01-19
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.